Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2020 | 10-2019 | 10-2018 | |
| Cash Flows From Operating Activities | |||
| Accounts receivable | 0 | 4 | -6 |
| Accounts payable and accrued liabilities | -6 | 4 | 5 |
| Other Working Capital | -23 | 32 | 1 |
| Other Operating Activity | -169 | -88 | -81 |
| Operating Cash Flow | $-199 | $-48 | $-80 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -8 | -8 | -100 |
| Other Investing Activity | 4 | 0 | 0 |
| Investing Cash Flow | $-4 | $-8 | $-100 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 488 | 0 | 160 |
| Other Financing Activity | -39 | 0 | -2 |
| Financing Cash Flow | $449 | $0 | $159 |
| Beginning Cash Position | 1 | 56 | 78 |
| End Cash Position | 248 | 1 | 56 |
| Net Cash Flow | $247 | $-55 | $-22 |
| Free Cash Flow | |||
| Operating Cash Flow | -199 | -48 | -80 |
| Capital Expenditure | -8 | -8 | -100 |
| Free Cash Flow | -206 | -55 | -180 |